TY - JOUR
T1 - Metabolic syndrome and arterial elasticity in youth
AU - Gardner, Andrew W.
AU - Parker, Donald E.
AU - Krishnan, Sowmya
AU - Chalmers, Laura J.
N1 - Funding Information:
This research was supported by the National Center on Minority Health and Health Disparities ( P20-MD-000528-05 ), and by the University of Oklahoma Health Sciences Center General Clinical Research Center grant ( M01-RR-14467 ), sponsored by the National Center for Research Resources from the National Institutes of Health .
PY - 2013/3
Y1 - 2013/3
N2 - Objective: To compare arterial elasticity in children, adolescents, and young adults with and without metabolic syndrome (MetS), and to assess which MetS components, demographic measures, and body composition measures are associated with arterial elasticity. Materials/Methods: Two-hundred six subjects (107 females and 99 males) between the ages of 10 and 20 years were recruited by local newspaper advertisements, university email advertisements, and informational flyers. Subjects were assessed on MetS components, demographic measures, body composition measures, and arterial elasticity via radial tonometry. Forty-five subjects (22%) had MetS, as defined by the International Diabetes Federation, and 161 subjects (78%) did not. Results: The primary novel finding was that group differences were not observed for large artery elasticity index (LAEI) (MetS = 16.1 ± 4.4 (ml × mmHg- 1) × 10 (mean ± SD), control = 15.4 ± 4.9, (ml × mmHg - 1) × 10, p = 0.349), and small artery elasticity index (SAEI) (MetS = 9.2 ± 2.7 (ml × mmHg- 1) × 100, control = 8.4 ± 2.9, (ml × mmHg- 1) × 100, p = 0.063). In the MetS group, fat free mass was positively associated with arterial elasticity, and was the strongest multivariate predictor of LAEI (partial R 2 = 0.41) and SAEI (partial R2 = 0.29). Conclusions: Youth with MetS did not exhibit differences in LAEI and SAEI compared to controls. Furthermore, fat free mass of youth with MetS was positively associated with arterial elasticity, and was the strongest predictor of both LAEI and SAEI. The clinical implication is that exercise intervention designed to increase fat free mass might increase arterial elasticity in youth, particularly in youth with MetS.
AB - Objective: To compare arterial elasticity in children, adolescents, and young adults with and without metabolic syndrome (MetS), and to assess which MetS components, demographic measures, and body composition measures are associated with arterial elasticity. Materials/Methods: Two-hundred six subjects (107 females and 99 males) between the ages of 10 and 20 years were recruited by local newspaper advertisements, university email advertisements, and informational flyers. Subjects were assessed on MetS components, demographic measures, body composition measures, and arterial elasticity via radial tonometry. Forty-five subjects (22%) had MetS, as defined by the International Diabetes Federation, and 161 subjects (78%) did not. Results: The primary novel finding was that group differences were not observed for large artery elasticity index (LAEI) (MetS = 16.1 ± 4.4 (ml × mmHg- 1) × 10 (mean ± SD), control = 15.4 ± 4.9, (ml × mmHg - 1) × 10, p = 0.349), and small artery elasticity index (SAEI) (MetS = 9.2 ± 2.7 (ml × mmHg- 1) × 100, control = 8.4 ± 2.9, (ml × mmHg- 1) × 100, p = 0.063). In the MetS group, fat free mass was positively associated with arterial elasticity, and was the strongest multivariate predictor of LAEI (partial R 2 = 0.41) and SAEI (partial R2 = 0.29). Conclusions: Youth with MetS did not exhibit differences in LAEI and SAEI compared to controls. Furthermore, fat free mass of youth with MetS was positively associated with arterial elasticity, and was the strongest predictor of both LAEI and SAEI. The clinical implication is that exercise intervention designed to increase fat free mass might increase arterial elasticity in youth, particularly in youth with MetS.
UR - http://www.scopus.com/inward/record.url?scp=84874113824&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84874113824&partnerID=8YFLogxK
U2 - 10.1016/j.metabol.2012.09.008
DO - 10.1016/j.metabol.2012.09.008
M3 - Article
C2 - 23142161
AN - SCOPUS:84874113824
SN - 0026-0495
VL - 62
SP - 424
EP - 431
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
IS - 3
ER -